Fatal	fatal	O	O	O	O
haemorrhagic	haemorrhagic	O	O	OTHERS	I
myocarditis	myocarditis	O	DISEASE	OTHERS	I
secondary	secondary	O	O	O	O
to	to	O	O	O	O
cyclophosphamide	cyclophosphamide	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
.	.	O	O	O	O

Haemorrhagic	haemorrhagic	O	O	OTHERS	I
myocarditis	myocarditis	O	DISEASE	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
rare	rare	O	O	O	O
but	but	O	O	O	O
important	important	O	O	O	O
complication	complication	O	O	O	O
of	of	O	O	O	O
cyclophosphamide	cyclophosphamide	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
.	.	O	O	O	O

Echocardiographic	echocardiographic	O	O	O	O
identification	identification	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
disorder	disorder	O	O	O	O
can	can	O	O	O	O
be	be	O	O	O	O
made	made	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
believe	believe	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
ultrasound	ultrasound	O	O	O	O
features	features	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
disorder	disorder	O	O	O	O
have	have	O	O	O	O
not	not	O	O	O	O
been	been	O	O	O	O
previously	previously	O	O	O	O
reported	reported	O	O	O	O
.	.	O	O	O	O

